3 min read Business Akums Reports 32% Revenue Growth, 106% EBITDA Growth and 168% PAT Growth in Q2 FY27 November 6, 2026 timesofgujarat New Delhi, 3 November 2026: Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development...
